Cross Country Healthcare, Inc.

As of November 6, 2024, Cross Country Healthcare, Inc. is considered overvalued and risky due to negative returns on capital and equity, high EV to EBITDA ratio compared to peers, and significant underperformance against the S&P 500.

As of November 6, 2024, Cross Country Healthcare, Inc. is considered risky and overvalued due to a negative P/E ratio and weak financial metrics, significantly underperforming the S&P 500 with a year-to-date return of -26.76%.

As of June 17, 2025, the market trend is mildly bearish, with weekly indicators showing bearish signals while monthly indicators suggest mild bullishness, resulting in overall negative sentiment and underperformance against the S&P 500.

As of March 2022, the management team of Cross Country Healthcare, Inc. includes Mr. Thomas Dircks (Independent Chairman), Mr. Kevin Clark (CEO), Mr. W. Larry Cash (Lead Independent Director), and several independent directors including Janice Nevin, Gale Fitzgerald, Darrell Freeman, and Mark Perlberg. They oversee the company's operations and strategic direction.

Cross Country Healthcare, Inc. provides healthcare recruiting, staffing, and workforce solutions, operating as a micro-cap company with a market cap of $457.33 million. As of March 2025, it reported net sales of $293 million but no net profit.

As of Jun 18, Cross Country Healthcare, Inc. has a market capitalization of 457.33 million and reported net sales of 1,258.24 million with a net profit of -17.73 million over the latest four quarters. Shareholder's Funds are at 418.96 million and Total Assets at 589.25 million as of Dec 24.